ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,918.25
0.00%
Dow Jones
42,635.20
0.00%
US Dollar vs MXN
20.50236
0.41%
Brent Oil
76.835
1.11%
Bitcoin
92,583.41
-2.60%
Pepperstone
Advertisement
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. USOTC

  6. Scopus BioPharma Inc (CE) (SCPS) Cotización

Scopus BioPharma Inc (CE)

Scopus BioPharma Inc (CE) (SCPS)

USOTC
0.0003
0.00
(0.00%)
Cerrado 09 Enero 3:00PM
Delayed by 15 minutes

Mejore su cartera: debates en tiempo real e ideas comerciales prácticas.

Premium

Estadísticas y detalles clave

Último Precio
0.0003
Postura de Compra
0.00
Postura de Venta
0.00
Volume Operado de la Acción
-
0.00 Rango del Día 0.00
0.000001 Rango de 52 semanas 0.0637
Capitalización de Mercado [m]
12.625k
Precio Anterior
0.0003
Precio de Apertura
-
Hora
Última hora de negociación
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
17,277
Acciones en circulación
42,084,264
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-0.62
Beneficio por acción (BPA)
-0.28
turnover
-
Beneficio neto
-11.61M

Acerca de Scopus BioPharma Inc (CE)

Scopus BioPharma Inc. is a biopharmaceutical company developing transformational therapeutics for serious diseases with significant unmet medical need. We are currently focusing our development efforts on our immuno-oncology programs, which are conducted primarily through Duet BioTherapeutics Inc. (... Scopus BioPharma Inc. is a biopharmaceutical company developing transformational therapeutics for serious diseases with significant unmet medical need. We are currently focusing our development efforts on our immuno-oncology programs, which are conducted primarily through Duet BioTherapeutics Inc. (Duet), our majority-owned subsidiary. These programs include three distinctive complementary CpG-STAT3 inhibitors: Antisense ("DUET-101"); RNA silencing ("DUET-202"); and DNA-binding inhibitor ("DUET-301"). The Company may also seek to develop additional drug candidates and identify additional compelling technologies for potential acquisition, in-licensing and/or other similar transactions. Mostrar más

Sector
Pharmaceutical Preparations
Industria
Pharmaceutical Preparations
Sitio web
www.scopusbiopharma.com
Sede
Wilmington, Delaware, USA
Fundado
-
Scopus BioPharma Inc (CE) is listed in the Pharmaceutical Preparations sector of the OTCMarkets with ticker SCPS. The last closing price for Scopus BioPharma (CE) was US$0. Over the last year, Scopus BioPharma (CE) shares have traded in a share price range of US$ 0.000001 to US$ 0.0637.

Scopus BioPharma (CE) currently has 42,084,264 shares in issue. The market capitalisation of Scopus BioPharma (CE) is US$12,625.28 . Scopus BioPharma (CE) has a price to earnings ratio (PE ratio) of -0.62.

SCPS Últimas noticias

Más noticias

Form 1-Z -

09 Febrero 2024
Edgar (US Regulatory)

Form 15-12G - Securities registration termination [Section 12(g)]

19 Enero 2024
Edgar (US Regulatory)

Form 8-K - Current report

18 Agosto 2023
Edgar (US Regulatory)

Form 8-K - Current report

11 Agosto 2023
Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

11 Agosto 2023
Edgar (US Regulatory)

Form DEF 14A - Other definitive proxy statements

21 Julio 2023
Edgar (US Regulatory)

Form PRER14A - Preliminary Proxy Soliciting materials

28 Junio 2023
Edgar (US Regulatory)
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1000.00030.00030.000330420.0003CS
4000.00030.00030.000261710.00029989CS
12-0.0001-250.00040.010.0002172770.00031519CS
260.000299299001.0E-60.011.0E-6121970.00030805CS
52-0.0417-99.28571428570.0420.06371.0E-694240.00546302CS
156-0.0848-99.64747356050.08510.1561.0E-6242390.07277666CS
260-0.0848-99.64747356050.08510.1561.0E-6242390.07277666CS

SCPS - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Scopus BioPharma (CE)?
El precio actual de las acciones de Scopus BioPharma (CE) es US$ 0.0003
¿Cuántas acciones de Scopus BioPharma (CE) están en circulación?
Scopus BioPharma (CE) tiene 42,084,264 acciones en circulación
¿Cuál es la capitalización de mercado de Scopus BioPharma (CE)?
La capitalización de mercado de Scopus BioPharma (CE) es USD 12.63k
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Scopus BioPharma (CE)?
Scopus BioPharma (CE) ha negociado en un rango de US$ 0.000001 a US$ 0.0637 durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Scopus BioPharma (CE)?
El ratio precio/beneficio de Scopus BioPharma (CE) es -0.62
¿Cuál es la moneda de reporte de Scopus BioPharma (CE)?
Scopus BioPharma (CE) presenta sus resultados financieros en USD
¿Cuál es el último beneficio anual de Scopus BioPharma (CE)?
El último beneficio anual de Scopus BioPharma (CE) es USD -11.61M
¿Cuál es la dirección registrada de Scopus BioPharma (CE)?
La dirección registrada de Scopus BioPharma (CE) es CORPORATION TRUST CENTER, 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
¿Cuál es la dirección del sitio web de Scopus BioPharma (CE)?
La dirección del sitio web de Scopus BioPharma (CE) es www.scopusbiopharma.com
¿En qué sector industrial opera Scopus BioPharma (CE)?
Scopus BioPharma (CE) opera en el sector PHARMACEUTICAL PREPARATIONS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
AABVFAberdeen International Inc (PK)
US$ 0.0304
(0.00%)
0
AABKFAareal Bank AG (PK)
US$ 0.00
(0.00%)
0
AABBAsia Broadband Inc (PK)
US$ 0.0308
(0.00%)
0
AAALYAareal Bank AG (PK)
US$ 34.65
(0.00%)
0
AAAIFAlternative Investment Trust (PK)
US$ 0.55
(0.00%)
0
AABVFAberdeen International Inc (PK)
US$ 0.0304
(0.00%)
0
AABKFAareal Bank AG (PK)
US$ 0.00
(0.00%)
0
AABBAsia Broadband Inc (PK)
US$ 0.0308
(0.00%)
0
AAALYAareal Bank AG (PK)
US$ 34.65
(0.00%)
0
AAAIFAlternative Investment Trust (PK)
US$ 0.55
(0.00%)
0
AABVFAberdeen International Inc (PK)
US$ 0.0304
(0.00%)
0
AABKFAareal Bank AG (PK)
US$ 0.00
(0.00%)
0
AABBAsia Broadband Inc (PK)
US$ 0.0308
(0.00%)
0
AAALYAareal Bank AG (PK)
US$ 34.65
(0.00%)
0
AAAIFAlternative Investment Trust (PK)
US$ 0.55
(0.00%)
0

Discusión

Ver feed completo
Ooou812 Ooou812 2 minutos hace
style="caret-color: rgb(35, 42, 49); color: rgba(35, 42, 49, 1); font-family: "GT America", "Yahoo Sans", YahooSans, "Helvetica Neue", Helvetica, Arial, sans-serif; font-size: 31.5px; background-color: rgba(255, 255, 255, 1)"During the interview, Dr. Baratz also highlighted that "D-Wave has been abl
RGTI
alertmeipp alertmeipp 2 minutos hace
There is no better feeling

Agree, hope we get to enjoy the feeling with ENTA soon. I made ok money with RVNC buyout offer and another one in energy sector recently. Both companies were undervalued with good quality assets and the assets would worth more under larger companies.
ENTA RVNC
mouton29 mouton29 2 minutos hace
Had no idea a video was attached to said post. I rarely if ever use a computer for access to I-Hub.

I generally use my phone as well but use a bookmark to the website as the app is missing features, such as displaying videos and putting text into quote format.
ENTA
urge2surge urge2surge 3 minutos hace
Wednesday was a bear raid. Nothing more than a shake for shares.
AEHL
nowwhat2 nowwhat2 4 minutos hace
Well now - How's about YOU draw it ?......yes ? No ?

SHOW US where you see that in this ;

https://investorshub.advfn.com/uimage/uploads/2025/1/9/iortfbtc_!_9_6m_7am_horiz_RED_OVAL_2_NEW.jpg


Just take THAT chart and draw THIS in ; Because I'd feel
XRPUSD
Hardazoak Hardazoak 4 minutos hace
Not all, only bashers should be punished for spreading misleading information and straight out lies.
AABB
Zephos Zephos 4 minutos hace
Given that this stock is "revoked and never coming back," are certain posters just gonna spend the rest of their lives reminding us? Hasn't stopped them so far. Odd behavior, if you ask me.
HGilS HGilS 4 minutos hace
https://www.marketwatch.com/story/dodge-the-401-k-and-ira-ticking-tax-time-bomb-by-going-all-in-on-roths-expert-says-13f1f6df?mod=article_inline

Dodge the 401K and IRA ticking tax bomb article.
ELTP
RickNagra RickNagra 5 minutos hace
The Phillips news came out this morning.
FNMA
NoMoDo NoMoDo 5 minutos hace
Wow, I said that? Could you point to where I specifically said that?nomodo proclaimed "Next week it will be $.10 -- count on it.
HMBL
tedpeele tedpeele 5 minutos hace
Buy some more puts X. Being bedazzled-by-shiny objects isn't really something to be proud of X.

While there can be value in talking to management in person - many people have bought into many pie-in-the skies and con jobs after visiting 'in person' too.

What really matt
LWLG
moola26 moola26 7 minutos hace
YIKES!! Did Koan just school these non shareholders again. Ouch!

We are so special to get all this attention by non shareholder lawyers .
2025$$$$

MAJORITY HOLDING STRONG$$$$l
BottomBounce BottomBounce 7 minutos hace
TeraWulf Inc $WULF Total Debt (mrq) $912k Book Value only $.95
WULF
BottomBounce BottomBounce 8 minutos hace
Cipher Mining Inc. $CIFR Total Debt (mrq) $23.16M
CIFR
Peter J Peter J 8 minutos hace
Again why are you here???? Quit asking questions that you wont answer yourself.

Eh, that question comes from the guy with 6400 ERHC posts in his name? 🤣
You altruists guys have the biggest balls in the country... for sure. 💪

I certainly can answer
ERHE
blownaccount9 blownaccount9 9 minutos hace
I looked at their resumes. Priscilla looks awesome and what she’s been saying gives me faith in her as a shareholder. Idk about the other but her resume looked solid too.
FNMA
DTGoody DTGoody 9 minutos hace
Wow Awesome call on $CAPC JTHawk! I seen your original post before it was taken down by admins for some reason. I am not sure why it was removed as this is a general discussion board including stock picks. Because it was removed by ADMIN this was the only reason, I didn't restore it.
Excell
CAPC
tuzedaze tuzedaze 9 minutos hace
Let’s get uplisted before we do anything
FNMA
WolfofMia WolfofMia 9 minutos hace
TRY THIS: Q) Please provide any examples of drugs approved by the FDA, where an open label extension (OLE) trial was accepted in addition to a randomized controlled p2b/p3 trial.


ChatGPT

Thought for 4 seconds
Open-label extension (OLE) trials are valuable
AVXL
Double DD Double DD 9 minutos hace
Loading more here!! 
GCTK
gfp927z gfp927z 9 minutos hace
Heard it in a Love Song -


https://www.youtube.com/watch?v=SiLUTWcLCgU



---
STL Stock STL Stock 10 minutos hace
I think it infuriates the so called "bashers" that the ticker was supposed to be at no bid in Q3-Q4 and it ran 2400% in December. Bulls are winning right now. Which is refreshing since its been a bear party since i bought in last year. But bulls are currently winning looking at the SP. And have been
HMBL
Ooou812 Ooou812 10 minutos hace
style="caret-color: rgb(35, 42, 49); color: rgba(35, 42, 49, 1); font-family: "GT America", "Yahoo Sans", YahooSans, "Helvetica Neue", Helvetica, Arial, sans-serif; font-size: 31.5px; background-color: rgba(255, 255, 255, 1)"During the interview, Dr. Baratz also highlighted that "D-Wave has been abl
QBTS
Mr. C Mr. C 10 minutos hace
“Delfin is in the process of preparing materials required by MARAD in its continuing effort to obtain the DWPA license. Delfin is hopeful that MARAD will complete the supplemental NEPA process and issue that license expeditiously.”

NEPA (National Environmental Policy Act) is the law t
TGLO
BottomBounce BottomBounce 10 minutos hace
Core Scientific, Inc. $CORZ Total Debt (mrq) $567.74M
CORZ

Su Consulta Reciente

USOTC
SCPS
Scopus BioPharma (CE)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2025 ADVFN PLC - Todos los derechos reservados